Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 mass balance and metabolism study of [14C]PF-07104091 in healthy adult men
NL-OMON60166Phase 1Completed
- Sponsor
- Pfizer
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tegtociclib, sponsored by Pfizer. Primary endpoint: Primary endpoint(s). Started Aug 2025; status: completed.
02
Drugs
tegtociclib
Beyond the preview
Go deeper on NL-OMON60166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60166.